Fortress Biotech, Inc. - ROE
FBIO
Price:
$2.99
Market Cap:
$99.33M
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases). Other products in this segment are Exelderm cream for fungal skin infections like ringworm and jock itch, Ceracade for dry skin conditions, Luxamend for wound care, and Accutane capsules for particularly severe, stubborn nodular acne. Its pipeline features several promising late-stage drug candid...[Read more]
Industry
Biotechnology
IPO Date
2011-11-17
Stock Exchange
NASDAQ
Ticker
FBIO
PE Ratio
[0.93]
ROE
[163.88%]
Current Ratio
[2.86]
Dividend Yield
[0%]
Enterprise Value
[-102888975.00]
Dividend History
The ROE as of June 2026 (TTM) for Fortress Biotech, Inc. (FBIO) is 163.88%
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is 163.88%. This represents a change of 519.12% compared to the average of 26.47% of the last 4 quarters.
Fortress Biotech, Inc. (FBIO) Historical ROE (quarterly & annually)
How has FBIO ROE performed in the past?
The mean historical ROE of Fortress Biotech, Inc. over the last ten years is -573.74%. The current 163.88% ROE has changed -128.56% with respect to the historical average. Over the past ten years (40 quarters), FBIO's ROE was at its highest in in the March 2026 quarter at 68.04%. The ROE was at its lowest in in the December 2018 quarter at -1343.41%.
Average
-573.74%
Median
-147.78%
Minimum
-4543.57%
Maximum
13.66%
Fortress Biotech, Inc. (FBIO) ROE by Quarter and Year
Discovering the peaks and valleys of Fortress Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.47%
Maximum Annual ROE = 13.66%
Minimum Annual Increase = -106.75%
Minimum Annual ROE = -4543.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | 13.66% | -106.75% |
| 2024 | -202.30% | -24.79% |
| 2023 | -268.97% | 29.62% |
| 2022 | -207.51% | 248.53% |
| 2021 | -59.54% | 28.40% |
| 2020 | -46.37% | -69.58% |
| 2019 | -152.43% | -96.65% |
| 2018 | -4543.57% | 3.47% |
| 2017 | -127.21% | -11.12% |
| 2016 | -143.12% | 68.00% |
Fortress Biotech, Inc. (FBIO) Average ROE
How has FBIO ROE performed in the past?
The current ROE of Fortress Biotech, Inc. (FBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-152.54%
5-year avg
-144.93%
10-year avg
-573.74%
Fortress Biotech, Inc. (FBIO) ROE vs. Peers
How is FBIO’s ROE compared to its peers?
Fortress Biotech, Inc.’s ROE is greater than XBiotech Inc. (-26.10%), greater than Nutriband Inc. (-112.60%), less than Vaxart, Inc. (61.43%), greater than CervoMed Inc. (-136.08%), greater than Adagene Inc. (-48.20%), greater than Relmada Therapeutics, Inc. (-71.22%), greater than Gain Therapeutics, Inc. (-201.43%), greater than TScan Therapeutics, Inc. (-91.94%), greater than Immunic, Inc. (-220.75%), greater than PMV Pharmaceuticals, Inc. (-68.98%),
| Company | ROE | Market cap |
|---|---|---|
| -26.10% | $70.43M | |
| -112.60% | $35.25M | |
| 61.43% | $133.12M | |
| -136.08% | $39.26M | |
| -48.20% | $148.34M | |
| -71.22% | $493.54M | |
| -201.43% | $80.19M | |
| -91.94% | $56.19M | |
| -220.75% | $140.13M | |
| -68.98% | $60.26M |
Build a custom stock screener for Fortress Biotech, Inc. (FBIO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Fortress Biotech, Inc. (FBIO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Fortress Biotech, Inc.'s ROE?
How is the ROE calculated for Fortress Biotech, Inc. (FBIO)?
What is the highest ROE for Fortress Biotech, Inc. (FBIO)?
What is the 3-year average ROE for Fortress Biotech, Inc. (FBIO)?
What is the 5-year average ROE for Fortress Biotech, Inc. (FBIO)?
How does the current ROE for Fortress Biotech, Inc. (FBIO) compare to its historical average?